Leaderboard

En | De
No articles selected!     View Cart  
You are here: Oncology » Blood 06. March 2026
Search
medline.ch
Blood
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 8315  Previews Next
   
   Articles 1 - 20 / 166296  
   
Understanding hairy cell leukemia in the context of mature B-cell neoplasms: tumor microenvironment and extracellular vesicle contribution to disease pathogenesis.
Front Immunol
Ingangi V, Amoroso D, Passaro E, Di Vaia V, Maltoni F, Narimanfar G, Minopoli M, Rosa R, Ametrano M, Di Gennaro E, Broccoli A, Zinzani PL, Catani L, Ciardiello C.
PMID: 41789071 [PubMed - in process]


From genetic variants to therapeutic targets: A study reveals MMS19 and HLA genes in Hodgkin lymphoma pathogenesis.
Br J Haematol
Fu YC, Liu LP, Zhou YP, Yang MH.
PMID: 41787912 [PubMed - as supplied by publisher]


BET inhibitor OPN-2853 in advanced solid tumors and lymphoma: results from the phase 1b PLX124-01 trial.
Cancer Chemother Pharmacol
Gordon MS, Carvajal RD, Spira A, Huang M, Inokuchi K, Chen PY, Matusow B, Bollag G, Walling J, Patnaik A.
PMID: 41787121 [PubMed - in process]


Effect of stepwise nutritional intervention based on GLIM standard on children with leukemia undergoing transplantation: a retrospective study.
Sci Rep
Wang C, Ni N, Zhao B, Zhang S, Zhang Y.
PMID: 41786855 [PubMed - as supplied by publisher]


Effects of induction-phase acute kidney injury and age at diagnosis on chronic kidney disease in pediatric acute lymphoblastic leukemia: a time-to-event cohort study.
Clin Exp Pediatr
Phongphiew P, Penboon N, Chiengthong K, Rianthavorn P.
PMID: 41786346 [PubMed - as supplied by publisher]


Efficacy of zanubrutinib in diffuse large B-cell lymphoma: A single-arm meta-analysis.
Crit Rev Oncol Hematol
Sun P, Yang H, Li B, Wang Y, Liu P, Li Z.
PMID: 41786108 [PubMed - as supplied by publisher]


Executive Summary of the American Radium Society Appropriate Use Criteria for Extranodal NK/T-Cell Lymphoma.
Int J Radiat Oncol Biol Phys
Dandapani SV, Ahmed S, Robinson T, Advani R, Bates J, Constine LS, Dabaja B, Ha CS, Hoppe BS, Vega RM, Peterson JL, Pinnix CC, Plastaras J, Shaaban SG, Wu SY, Milgrom SA.
PMID: 41785936 [PubMed - as supplied by publisher]


Impact of FMS-like tyrosine kinase 3 inhibitor maintenance on post-transplant outcomes in acute myeloid leukemia with FMS-like tyrosine kinase 3 mutations: a real-world German registry analysis highlighting sorafenib.
Haematologica
Massoud R, Flossdorf S, Hanke F, Schroeder T, Bethge W, Zeiser R, Pabst C, Wulf G, Sala E, Hilgendorf I, Scheid C, Edinger M, Stölzel F, Blau IW, Stelljes M, Kobbe G, Platzbecker U, Bittenbring JT, Eder M, Fleischhauer K, Burchert A, Schmid C, Kröger N.
PMID: 41784041 [PubMed - as supplied by publisher]


Epcoritamab plus rituximab, dexamethasone, cytarabine, oxaliplatin/carboplatin induces deep and durable responses in transplant-eligible patients with relapsed or refractory diffuse large B-cell lymphoma: results from the EPCORE NHL-2 trial.
Haematologica
Abrisqueta P, Karimi YH, Morillo D, Cordoba R, Phillips T, De Vos S, Nijland M, Offner F, Andersson PO, Brody J, Cheah CY, Prieto PG, Hellström M, Jørgensen JM, Lewis D, Linton KM, Musuraca G, Wang L, Marek J, Osei-Bonsu K, Risum M, Falchi L.
PMID: 41784015 [PubMed - as supplied by publisher]


Feasibility of Salvage Therapy With High-Dose Bendamustine and Rituximab Based on a Series of Two Cases From a Planned Phase II Trial for Relapsed/Refractory Diffuse Large B-cell Lymphoma.
Cureus
Murai K, Hiramatsu Y, Kiguchi T, Uoshima N, Tamai Y, Fukushima K, Furukawa T, Hoshiko T, Takamori A, Mitsutake T, Yoshida N, Kimura S, Terui Y.
PMID: 41783874 [PubMed]


Real-World Analysis of Outcomes of Venetoclax+Azacitidine Versus 7+3 Induction in Acute Myeloid Leukemia.
EJHaem
Guevara Rodriguez N, Mercado NC, Kamal SAF, Beesabathina S, Foster D, Rajeh N, Kunwor R.
PMID: 41782644 [PubMed]


Movement disorders due to primary central nervous system lymphoma: An illustrative case and systematic literature review.
Rev Neurol (Paris)
Harlay V, Mira V, Petrirena G, Bertucci A, Tabouret E, Schenone L, Grimaldi S.
PMID: 41781302 [PubMed - as supplied by publisher]


Systematic Review of Real-World Data on the Effectiveness and Safety Profiles of First-Line Therapies in Chronic Lymphocytic Leukemia.
Crit Rev Oncol Hematol
Sto, Ma, Janiszewska K, Kawalec P.
PMID: 41780654 [PubMed - as supplied by publisher]


Measurable residual disease detection in acute leukemia: Technological advances and clinical translation.
Leuk Res
Wang M, Li J.
PMID: 41780199 [PubMed - as supplied by publisher]


Evaluation of Chemotherapy Efficacy in Primary Gastric Diffuse Large B-cell Lymphoma on a Point-based Scoring System: A Multicenter Study.
Clin Oncol (R Coll Radiol)
Yu S, Cai M, Guan Y, Liu X, Li P.
PMID: 41780126 [PubMed - as supplied by publisher]


Causes of excess non-lymphoma death in 58,000 patients with DLBCL diagnosed during 1997-2020 and followed for up to 25 years.
Blood Adv
Challenger A, McGale P, Probert J, Barrett A, Broggio J, Collins GP, Kayiparambil Harish K, Roden L, Royston D, Wang Z, Darby SC, Cutter DJ.
PMID: 41779974 [PubMed - as supplied by publisher]


OUTCOMES OF PATIENTS OVER 70 YEARS TREATED WITH BREXU-CEL FOR R/R MANTLE CELL LYMPHOMA: A STUDY FROM THE CTIWP OF EBMT.
Blood Adv
Santoro N, Mooyaart JE, Novak U, Protheroe R, Ayuk FA, Dreger P, van Meerten T, Paneesha S, Sanderson R, Ram R, Northend M, Forcade E, Huynh A, Yakoub-Agha I, Hoogenboom JD, Coelho MHM, Pagliuca S, Malard F, Kuball J, Sureda A, Bazarbachi A, Ruggeri A, Rocha V.
PMID: 41779968 [PubMed - as supplied by publisher]


A phase 1 trial of romidepsin, azacitidine, dexamethasone and lenalidomide in relapsed or refractory T-cell lymphoma.
Blood Adv
Gordon MJ, Miljkovic MD, Milhon P, Lakhotia R, Melani C, Johnson K, Bryant BR, Pittaluga S, Jaffe ES, Conlon KC, Staudt LM, Wilson W, Roschewski M, Ng SY.
PMID: 41779512 [PubMed - as supplied by publisher]


BCR::ABL1 Mutational Profiling in US Patients With Chronic-phase Chronic Myeloid Leukemia on Tyrosine Kinase Inhibitors.
Cancer Diagn Progn
Haddad FG, Jabbour EJ, Gutkin SW, Pathak AK, Zhai Y, Kantarjian HM.
PMID: 41778234 [PubMed]


The oncogenic role of ecotropic viral integration site 1 in hematological malignancies: mechanisms of activation and leukemogenesis.
Front Immunol
Hao Y, Liu J, Lou J, Yan J.
PMID: 41777888 [PubMed - indexed for MEDLINE]


   
   Articles 1 - 20 / 166296    Page 1 of 8315  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1